Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avenue Therapeutics Inc.

0.3110
-0.0190-5.76%
Mar 28 16:00 EST
Volume:15.91K
Turnover:4.92K
Market Cap:638.75K
PE:-0.02
High:0.3265
Open:0.3070
Low:0.3000
Close:0.3300
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
More
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
Loading ...

Company Profile

Company Name:
Avenue Therapeutics Inc.
Exchange:
PINK
Establishment Date:
2015
Employees:
3
Office Location:
1111 Kane Concourse,Suite 301,Bay Harbor Islands,Florida,United States
Zip Code:
33154
Fax:
- -
Introduction:
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of rare and neurologic diseases in the United States. Its lead product candidate includes AJ201, which in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous (IV) Tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. Avenue Therapeutics, Inc. was incorporated in 2015 and is based in Tampa, Florida.

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."